These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10450680)

  • 1. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial glucose uptake measured with fluorodeoxyglucose: a proposed method to account for variable lumped constants.
    Bøtker HE; Goodwin GW; Holden JE; Doenst T; Gjedde A; Taegtmeyer H
    J Nucl Med; 1999 Jul; 40(7):1186-96. PubMed ID: 10405141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
    Nielsen R; Jorsal A; Iversen P; Tolbod L; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2018 Feb; 25(1):169-176. PubMed ID: 27473218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.
    Fallavollita JA; Luisi AJ; Yun E; deKemp RA; Canty JM
    J Nucl Cardiol; 2010 Aug; 17(4):637-45. PubMed ID: 20387134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders].
    Maes A; Nuyts J
    Verh K Acad Geneeskd Belg; 1997; 59(3):133-60. PubMed ID: 9490915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction.
    Czernin J; Porenta G; Brunken R; Krivokapich J; Chen K; Bennett R; Hage A; Fung C; Tillisch J; Phelps ME
    Circulation; 1993 Sep; 88(3):884-95. PubMed ID: 8353915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive supply-demand ischemia with dobutamine increases glucose uptake in postischemic and remote myocardium.
    McFalls EO; Murad B; Her D; Liow JS; Kelly R; Marx D; Sikora J; Ward HB
    J Nucl Med; 2003 Jan; 44(1):85-91. PubMed ID: 12515880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
    Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
    Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
    Ng CK; Soufer R; McNulty PH
    J Nucl Med; 1998 Mar; 39(3):379-83. PubMed ID: 9529278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
    Iozzo P; Chareonthaitawee P; Di Terlizzi M; Betteridge DJ; Ferrannini E; Camici PG
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1163-71. PubMed ID: 11934683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications.
    Tavares de Melo MD; Giorgi MCP; Assuncao AN; Dantas RN; Araujo Filho JA; Parga Filho JR; Bierrenbach ALS; de Lima CR; Soares J; Meneguetti JC; Mady C; Hajjar LA; Kalil Filho R; Bocchi EA; Salemi VMC
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):915-921. PubMed ID: 28379356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.
    Ko KY; Wang SY; Yen RF; Shiau YC; Hsu JC; Tsai HY; Lee CL; Chiu KM; Wu YW
    J Nucl Cardiol; 2020 Feb; 27(1):269-279. PubMed ID: 30109593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts.
    Simões MV; Egert S; Ziegler S; Miyagawa M; Reder S; Lehner T; Nguyen N; Charron MJ; Schwaiger M
    J Am Coll Cardiol; 2004 May; 43(9):1690-7. PubMed ID: 15120832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.